← Back to Search

Antibiotic

Tourniquet Use for Prosthetic Joint Infections

N/A
Recruiting
Led By Adam Hart, MD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two years for study completion
Awards & highlights

Study Summary

This trial examines the effects of tourniquet use during knee surgery on antibiotic distribution and tissue concentrations.

Who is the study for?
Adults aged 18-85 needing a primary total knee replacement due to conditions like osteoarthritis, rheumatoid arthritis, or avascular necrosis can join. Those with MRSA colonization, severe allergies to the study antibiotic, or severe kidney issues (eGFR < 30 ml/min) cannot participate.Check my eligibility
What is being tested?
The trial is testing how using a tourniquet during knee surgery affects the concentration of Ancef (an antibiotic) in tissue around the incision. It's looking at whether less blood flow from the tourniquet means less antibiotic gets to where it's needed.See study design
What are the potential side effects?
Potential side effects may include reduced distribution of antibiotics to affected tissues which could impact infection prevention. The use of a tourniquet might also cause discomfort or circulation issues in the leg.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two years for study completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and two years for study completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adipose tissue

Trial Design

2Treatment groups
Active Control
Group I: TourniquetActive Control1 Intervention
25 participants with tourniquet application
Group II: No tourniquetActive Control1 Intervention
25 participants without tourniquet application

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
449 Previous Clinical Trials
159,796 Total Patients Enrolled
Adam Hart, MDPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre
1 Previous Clinical Trials
200 Total Patients Enrolled

Media Library

Ancef (Antibiotic) Clinical Trial Eligibility Overview. Trial Name: NCT05604157 — N/A
Prosthetic Joint Infections Research Study Groups: Tourniquet, No tourniquet
Prosthetic Joint Infections Clinical Trial 2023: Ancef Highlights & Side Effects. Trial Name: NCT05604157 — N/A
Ancef (Antibiotic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05604157 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been enrolled in this trial thus far?

"Affirmative. According to the data located on clinicaltrials.gov, enrollment in this trial is open and ongoing; it was initially posted on September 16th 2021 and most recently edited November 2nd 2022. The medical research requires 50 participants from a single site."

Answered by AI

Do my qualifications meet the criteria for this research study?

"This clinical trial seeks to enroll 50 individuals that are between 18 and 85 years of age, who have prosthetic joint infections."

Answered by AI

Are individuals over the age of 55 eligible to participate in this investigation?

"This research is open to persons aged 18 and above, up until 85 years old."

Answered by AI

Are recruits still being sought for this research project?

"According to the clinicaltrials.gov database, enlistment is currently open for this medical study that was initially posted on September 16th 2021 and subsequently updated in November 2nd 2022."

Answered by AI
~19 spots leftby Dec 2025